SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Lupin’s arm achieves NABL accreditation across all greenfield labs

23 Apr 2025 Evaluate

Lupin’s wholly owned subsidiary -- Lupin Diagnostics (LDL) has achieved 100% National Accreditation Board for Testing and Calibration Laboratories (NABL) accreditation across all its greenfield labs.  This notable achievement highlights the adherence to rigorous quality control measures, reinforcing LDL’s unwavering dedication to providing top-tier diagnostic services. The company’s commitment to quality is reflected in every aspect of its operations, ensuring patients receive accurate and timely results that they can trust. 

Lupin is an innovation led transnational pharmaceutical company producing, developing and marketing a wide range of branded and generic formulations, biotechnology products and active pharmaceutical ingredients (APIs) globally.


Lupin Share Price

2256.50 -121.40 (-5.11%)
11-May-2026 12:00 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1877.45
Dr. Reddys Lab 1290.00
Cipla 1332.00
Zydus Lifesciences 945.20
Lupin 2256.50
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×